Lin NU, Borges V, Anders C, Murthy RK, et al. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial. J Clin Oncol 2020 May 29:JCO2000775. doi: 10.1200/JCO.20.00775.
PMID: 32468955